Cleary Gottlieb represented the sole bookrunner, Morgan Stanley, in an SEC-registered secondary offering of 2,775,000 shares of common stock of China Biologic Products, Inc. by Warburg Pincus.
The transaction closed on June 8, 2016.
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.
